Psoriatic Arthritis

Disease State Hub

Slideshows

Research Summaries

research summary

research summary

High Comorbidities, Risk Factors in Early PsA

09/21/2023

Leigh Precopio

In a recent study, researchers examined the prevalence of comorbidities and risk factors in individuals with newly diagnosed psoriatic arthritis.

09/21/2023

Research Summary

Male, Female Patients With Psoriatic Arthritis Treated With Tofacitinib Show Similar Responses, Key Differences

08/16/2023

Anthony Calabro, MA

In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.

08/16/2023

Research Summary

Secukinumab, Adalimumab Show Similar Efficacy for Enthesitis Resolution in Patients With Psoriatic Arthritis at 52 Weeks

08/10/2023

Anthony Calabro, MA

In a post hoc analysis of the EXCEED study, researchers found that secukinumab and adalimumab—two biologic disease-modifying antirheumatic medications—showed similar efficacy in the resolution of enthesitis...

08/10/2023

research summary

research summary

Efficacy, Safety of Risankizumab for Treatment of Active Psoriatic Arthritis

06/21/2023

Leigh Precopio

Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.

06/21/2023

research summary

Secukinumab Improves Disease Severity, Functional Outcomes for Psoriatic Arthritis

05/16/2023

Leigh Precopio

To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...

05/16/2023

September 2023

Current Issue

September 2023

Volume 63

Issue 9